215 related articles for article (PubMed ID: 8990537)
1. Discussion of "methodological controversies in the treatment of panic disorder".
Klein DF
Behav Res Ther; 1996; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537
[No Abstract] [Full Text] [Related]
2. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
3. Integrated treatment of panic disorder.
Rosenbaum JF; Pollock RA; Otto MW; Pollack MH
Bull Menninger Clin; 1995; 59(2 Suppl A):A4-26. PubMed ID: 7795571
[TBL] [Abstract][Full Text] [Related]
4. Psychopathology of panic attacks in panic disorder.
Uhlenhuth EH; Leon AC; Matuzas W
J Affect Disord; 2006 May; 92(1):55-62. PubMed ID: 16448702
[TBL] [Abstract][Full Text] [Related]
5. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
[TBL] [Abstract][Full Text] [Related]
6. Panic disorder with agoraphobia.
Klein DF
Br J Psychiatry; 1993 Dec; 163():835-7. PubMed ID: 7905776
[No Abstract] [Full Text] [Related]
7. A 15-year follow-up study of patients with panic disorder.
Andersch S; Hetta J
Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
[TBL] [Abstract][Full Text] [Related]
8. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder.
Nadiga DN; Hensley PL; Uhlenhuth EH
Depress Anxiety; 2003; 17(2):58-64. PubMed ID: 12621593
[TBL] [Abstract][Full Text] [Related]
9. Follow-up study of patients with panic disorder.
Judd FK; Burrows GD; Norman TR
Arch Gen Psychiatry; 1991 Sep; 48(9):860-2. PubMed ID: 1929779
[No Abstract] [Full Text] [Related]
10. Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia.
Spiegel DA; Roth M; Weissman M; Lavori P; Gorman J; Rush J; Ballenger J
Br J Psychiatry; 1993 Jun; 162():788-9; discussion 790-4. PubMed ID: 8101127
[No Abstract] [Full Text] [Related]
11. Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale.
Furukawa TA; Katherine Shear M; Barlow DH; Gorman JM; Woods SW; Money R; Etschel E; Engel RR; Leucht S
Depress Anxiety; 2009; 26(10):922-9. PubMed ID: 19006198
[TBL] [Abstract][Full Text] [Related]
12. Clinical issues in the long-term treatment of panic disorder.
Rosenbaum JF; Pollack MH; Pollock RA
J Clin Psychiatry; 1996; 57 Suppl 10():44-8; discussion 49-50. PubMed ID: 8917131
[TBL] [Abstract][Full Text] [Related]
13. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
14. Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
Albus M; Scheibe G; Scherer J
Psychopathology; 1995; 28(5):229-34. PubMed ID: 8559945
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia.
Marazziti D; Carlini M; Dell'Osso L
Curr Top Med Chem; 2012; 12(4):238-53. PubMed ID: 22204483
[TBL] [Abstract][Full Text] [Related]
16. [Panic disorder and agoraphobia: what is effective?].
Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E
Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719
[TBL] [Abstract][Full Text] [Related]
17. Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K; Schweizer E
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
[TBL] [Abstract][Full Text] [Related]
18. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
Oei TP; Llamas M; Evans L
Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
[TBL] [Abstract][Full Text] [Related]
19. Growing placebo response rate: the problem in recent therapeutic trials?
Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
[TBL] [Abstract][Full Text] [Related]
20. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
